Skip to content

Endoscopically assisted minimally invasive oral and maxillofacial surgical treatment

Endoscopically assisted minimally invasive oral and maxillofacial surgical treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083940
Enrollment
Unknown
Registered
2024-05-08
Start date
2018-05-29
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mid-cheek benign tumors

Interventions

Traditional surgery group:Patients undergo surgery via a conventional S-shaped preauricular and submandibular method.
Preauricular incision group:Patients undergo endoscopic-assisted surgery via a preauricular incision.
Transoral incision group:Patients undergo endoscopic-assisted surgery via a transoral incision approach.

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 65 Years

Inclusion criteria

Inclusion criteria: All patients were evaluated by ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) with a mass located in the mid-cheek region with a long-axis length =4 cm; the pathological diagnosis was benign tumor by aspiration biopsy. Patients aged 10~65 years old who could tolerate surgery under general anesthesia and had no contraindications to surgery were required. No history of radiotherapy or facial paralysis. All patients signed an informed consent form for this randomized study. Minors’ informed consent was obtained from their legal guardians for study participation. The informed consent to publish identifying information and images was obtained from patients.

Exclusion criteria

Exclusion criteria: Patients with too large tumors (long-axis length >4 cm), suspicious malignant tumors, acute inflammation, recurrent tumors, and those who could not complete or be lost to follow-up were excluded.

Design outcomes

Primary

MeasureTime frame
satisfaction with the aesthetic outcome;postoperative drainage amount and time;perioperative complications;incision length;estimated intraoperative blood loss;the conversion rate between open surgery and endoscopic-assisted surgery;tumor recurrence rate;

Secondary

MeasureTime frame
pathological results;maximum long-axis diameter of the tumor;operative time;follow-up time;

Countries

China

Contacts

Public ContactYong Wang

Department of Oral and Maxillofacial Surgery, Qilu Hospital of Shandong University, Jinan, China

13791123126@163.com+86 531 8216 6772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026